USPTO trademark

CAMENA BIOSCIENCE

RegisteredUSPTOWord markClass 1Class 42

"CAMENA BIOSCIENCE" is a word mark owned by Camena Bioscience Limited, filed at the USPTO on May 20, 2024. It is registered and covers classes 1 and 42.

Official USPTO record
CAMENA BIOSCIENCE trademark as filed
As filed with the USPTO
Status
Registered
Since June 17, 2025
Filed
May 20, 2024
Registered
June 17, 2025
Priority date
November 22, 2023
Claimed from United Kingdom
Application no.
98558966
Registration no.
7831639
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns CAMENA BIOSCIENCE

The owner and representative on file with the office.

Owner

Camena Bioscience Limited

SAFFRON WALDEN, Essex, United Kingdom

Representative

Jeffrey H. Greene

Foley & Lardner LLP

Goods and services

What the mark covers

The products and services CAMENA BIOSCIENCE is filed for, grouped by Nice class.

  • Chemicals for use in the biochemical and chemical industry; Chemical substances for use in the production of drugs, pharmaceuticals and antibodies; Active chemical ingredients for use in the production of drugs, pharmaceuticals and antibodies; DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for scientific and research use; Nucleic acids comprising synthetic nucleotides for scientific and research use; Synthetic DNA nucleotides, synthetic RNA nucleotides, synthetic genes being biotechnologically formed genes, synthetic oligonucleotides and synthetic proteins for laboratory, scientific and industrial use; Chemical preparations, namely, synthetic enzymes, gene editing enzymes, DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for laboratory, scientific and industrial purposes; Synthetic DNA and RNA nucleotides for scientific and medical research; Synthetic DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for use in medical biologics and therapeutics; Molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, XNA, oligonucleotides, genes and proteins

  • Consultancy in relation to biochemistry and biotechnology; Research and development in the field of biotechnology and synthetic biology; Biological analysis; Biotechnological research relating to enzymatic synthesis; Provision of gene synthesis solutions, namely, creating and modifying genetic sequences for scientific purposes; Development and test of enzyme production methods; Evaluations, estimates, research and preparing related reports and technical documentation of genetic materials all in the field of enzymatic production; Scientific and technological services in the field of biotechnology consisting of the development of innovative processes to produce synthetic genes; Genetic engineering, namely, production of nucleic acid sequences; Research and development services relating to the creation of synthetic nucleic acid sequences; Genetic engineering services being the design, development, and testing of synthetic gene sequences; Design, development, rental and leasing of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids and genetic materials; Genetic engineering services, namely, manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; Genetic engineering and scientific laboratory services being the design, development and testing of synthetic gene sequences in complex gene production; Research and development services in the field of nucleic acid synthesis technology; Technical consulting in the field of biotechnology; Genetic engineering, namely, production of complex gene sequences; Consultancy, advisory and information services related to the aforementioned services

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. On hold - electronic record review required
  7. Approved for pub - principal register
  8. Teas/email correspondence entered
  9. Correspondence received in law office
  10. Teas response to office action received

6 earlier steps on the official record.

FAQ

About CAMENA BIOSCIENCE

Who owns the trademark "CAMENA BIOSCIENCE"?

The USPTO trademark "CAMENA BIOSCIENCE" (application 98558966) is owned by Camena Bioscience Limited.

What is the status of "CAMENA BIOSCIENCE"?

Its status at the USPTO is: registered.

When was "CAMENA BIOSCIENCE" registered?

It was registered on June 17, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CAMENA BIOSCIENCE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2cea-2a40-7099-ba30-7a2f076e6793
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2cea-2a40-7099-ba30-7a2f076e6793",
  "object": "trademark",
  "mark_text": "CAMENA BIOSCIENCE",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98558966",
  "filing_date": "2024-05-20",
  "nice_classes": [
    1,
    42
  ],
  "owners": [
    {
      "name": "Camena Bioscience Limited",
      "entity_id": null
    }
  ]
}